000			04172nam a22004095i 4500
001			978-3-030-89891-5
003			DE-He213
005			20240729134651.0
007			cr nn 008mamaa
008			220128s2022 sz | s |||| 0|eng d
020			_a9783030898915 _9978-3-030-89891-5
024	7		_a10.1007/978-3-030-89891-5 _2doi
072		7	_aMJ _2bicssc
072		7	_aMED045000 _2bisacsh
072		7	_aMJ _2thema
245	1	0	_aUrologic Oncology _b : Multidisciplinary Care for Patients /
250			_a1st ed. 2022.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022.
300			_aX, 491 p. 30 illus., 23 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aCreating a Multidisciplinary GU Cancer Clinic -- Supportive and Palliative Care for Genitourinary Malignancies -- Operationalizing Genetic Testing in the Care of Patients with Prostate Cancer -- High-Risk Prostate Cancer -- Treatment of Metastatic Hormone Sensitive Prostate Cancer -- Expanding Options for M0 Castration Resistant Prostate Cancer (CRPC) -- Immunotherapy for Metastatic Prostate Cancer -- Advances in Prostate Cancer Imaging -- Bone Health Management -- Radiotherapy for Advanced Prostate Cancer -- Optimizing Perioperative Treatment for Kidney Cancer -- Surgical Treatment for Metastatic Kidney Cancer -- Targeted Therapy for Renal Cell Carcinoma -- Hereditary Cancer and Genetics in Renal Cell Carcinoma -- Immunotherapy in Renal Cell Carcinoma -- Evolving Treatment in Non-Muscle Invasive Bladder Cancer -- Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer -- Bladder-Sparing Approaches to Treatment of Muscle-Invasive Bladder Cancer -- Treatment of Metastatic Bladder Cancer -- Treatment of Upper Tract Urothelial Carcinoma.
520			_aUrologists and medical oncologists have witnessed a rapid growth in systemic therapeutic options for treating genitourinary malignancies that increasingly integrates radiation therapy to primary cancers, nodal beds, and even metastatic sites. The culmination of these advances has been the creation of multidisciplinary teams that expertly provide comprehensive care to patients with urologic cancers. This book provides the framework to create such a multidisciplinary clinical team focused on the treatment of urologic malignancies with representation from urologists, medical oncologists, and additional specialists who work together to provide optimal team-based care. The book integrates advanced systemic therapeutics including immune-based and targeted therapies. Readers gain a better understanding of the benefit of multidisciplinary co-management through specific examples such as hormone sensitive metastatic prostate cancer, neoadjuvant chemotherapy for muscle invasive bladder cancer, and immunotherapy approaches to advanced bladder and kidney cancer. The book also discusses the integration of genomic tumor characterization and personalized medicine into surgical planning, tumor biopsies, and chemo-immunotherapy selection, emphasizing the expansion of new therapeutics for urologic malignancies and the changing definitions of disease progression. Urologic Oncology: Multidisciplinary Care for Patients is a comprehensive resource for urologists, medical oncologists, radiation oncologists, genetic counselors, fellows in urologic oncology and medical oncology, residents in urology and radiation oncology, advanced practice providers, practice managers, and pharmaceutical representatives. .
650		0	_aInternal medicine. _96654
650	1	4	_aInternal Medicine. _96654
700	1		_aStratton, Kelly L. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aMorgans, Alicia K. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
856			_u#gotoholdings _yAccess resource
912			_aZDB-2-SME
912			_aZDB-2-SXM
245			_h[E-Book]
999			_c101855 _d101855